Found: 26
Select item for more details and to access through your institution.
Low SARS-CoV-2 antibody titers may be associated with poor clinical outcomes for patients with severe COVID-19.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12834-w
- By:
- Publication type:
- Article
Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.
- Published in:
- Emerging Infectious Diseases, 2021, v. 27, n. 2, p. 628, doi. 10.3201/eid2702.204088
- By:
- Publication type:
- Article
Back to normal; serological testing for COVID‐19 diagnosis unveils missed infections.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 7, p. 4549, doi. 10.1002/jmv.26949
- By:
- Publication type:
- Article
Seroconversion against SARS‐CoV‐2 occurred after the recovery in patients with COVID‐19.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 2, p. 692, doi. 10.1002/jmv.26495
- By:
- Publication type:
- Article
Five cluster classifications of long COVID and their background factors: A cross-sectional study in Japan.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 7, p. 3663, doi. 10.1007/s10238-023-01057-6
- By:
- Publication type:
- Article
Noonan syndrome‐associated biallelic LZTR1 mutations cause cardiac hypertrophy and vascular malformations in zebrafish.
- Published in:
- Molecular Genetics & Genomic Medicine, 2020, v. 8, n. 3, p. 1, doi. 10.1002/mgg3.1107
- By:
- Publication type:
- Article
Fever pattern and C-reactive protein predict response to rescue therapy in Kawasaki disease.
- Published in:
- Pediatrics International, 2016, v. 58, n. 3, p. 180, doi. 10.1111/ped.12762
- By:
- Publication type:
- Article
Discrepant Antigen-specific Antibody Responses Causing SARS-CoV-2 Persistence in a Patient Receiving B-cell-targeted Therapy with Rituximab.
- Published in:
- Internal Medicine, 2021, v. 60, n. 23, p. 3827, doi. 10.2169/internalmedicine.7884-21
- By:
- Publication type:
- Article
Epidemic of multiple Treponema pallidum strains in men who have sex with men in Japan: efficient multi-locus sequence typing scheme and indicator biomarkers.
- Published in:
- AIDS Research & Therapy, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12981-024-00663-y
- By:
- Publication type:
- Article
Amino acid catabolite markers for early prognostication of pneumonia in patients with COVID-19.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-44266-z
- By:
- Publication type:
- Article
Reversible diaphragmatic paralysis caused by a malpositioned chest tube.
- Published in:
- Cardiology in the Young, 2015, v. 25, n. 7, p. 1382, doi. 10.1017/S1047951114002546
- By:
- Publication type:
- Article
Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-10859-w
- By:
- Publication type:
- Article
Re-emerging threat of Trypanosoma cruzi vector transmission in El Salvador, update from 2018 to 2020.
- Published in:
- Infectious Diseases of Poverty, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40249-022-01008-5
- By:
- Publication type:
- Article
Age-adjusted impact of prior COVID-19 on SARS-CoV-2 mRNA vaccine response.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2023.1087473
- By:
- Publication type:
- Article
The landscape of drug resistance in Plasmodium falciparum malaria in the Democratic Republic of Congo: a mapping systematic review.
- Published in:
- Tropical Medicine & Health, 2023, v. 51, n. 1, p. 1, doi. 10.1186/s41182-023-00551-7
- By:
- Publication type:
- Article
Differential cardiomyocyte transcriptomic remodeling during in vitro Trypanosoma cruzi infection using laboratory strains provides implications on pathogenic host responses.
- Published in:
- Tropical Medicine & Health, 2023, v. 51, n. 1, p. 1, doi. 10.1186/s41182-023-00552-6
- By:
- Publication type:
- Article
Malaria infection among adults residing in a highly endemic region from the Democratic Republic of the Congo.
- Published in:
- Malaria Journal, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12936-024-04881-7
- By:
- Publication type:
- Article
Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19.
- Published in:
- Journal of Clinical Immunology, 2022, v. 42, n. 7, p. 1360, doi. 10.1007/s10875-022-01308-3
- By:
- Publication type:
- Article
Cloaking the ACE2 receptor with salivary cationic proteins inhibits SARS-CoV-2 entry.
- Published in:
- Journal of Biochemistry, 2022, v. 172, n. 4, p. 205, doi. 10.1093/jb/mvac054
- By:
- Publication type:
- Article
Successful treatment of fulminant and recurrent lymphocytic myocarditis with calcineurin inhibitors.
- Published in:
- ESC Heart Failure, 2024, v. 11, n. 5, p. 3430, doi. 10.1002/ehf2.14896
- By:
- Publication type:
- Article
Inflammatory cardiomyopathy of possibly overlapping aetiology: a case posing treatment dilemma and potential association.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 1, p. 761, doi. 10.1002/ehf2.13771
- By:
- Publication type:
- Article
Treatment of long COVID complicated by postural orthostatic tachycardia syndrome—Case series research.
- Published in:
- Journal of General & Family Medicine, 2024, v. 25, n. 1, p. 53, doi. 10.1002/jgf2.670
- By:
- Publication type:
- Article
Longitudinal ventilatory ratio monitoring for COVID-19: its potential in predicting severity and assessing treatment response.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Growth hormone deficiency: a possible complication of glucose transporter 1 deficiency?
- Published in:
- Acta Paediatrica, 2012, v. 101, n. 6, p. e259, doi. 10.1111/j.1651-2227.2012.02606.x
- By:
- Publication type:
- Article
Antibody Avidity Maturation Following Recovery From Infection or the Booster Vaccination Grants Breadth of SARS-CoV-2 Neutralizing Capacity.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 6, p. 780, doi. 10.1093/infdis/jiac492
- By:
- Publication type:
- Article
Factors impacting antibody kinetics, including fever and vaccination intervals, in SARS-CoV-2-naïve adults receiving the first four mRNA COVID-19 vaccine doses.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-57931-0
- By:
- Publication type:
- Article